Corbus Pharmaceuticals presented Phase 1 data on CRB-701 at ASCO GU, showing safety, tolerability, and responses across multiple tumor types.

Analysts at HC Wainwright issued their FY2029 earnings estimates for shares of Corbus Pharmaceuticals in a note issued to investors on Monday, February 10th. HC Wainwright analyst A. Maldonado expects ...

HC Wainwright reaffirmed their buy rating on shares of Corbus Pharmaceuticals (NASDAQ:CRBP – Free Report) in a research ...

Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP) stock has reached a 52-week low, trading at $9.1, reflecting a period of significant pressure for the biopharmaceutical company. With a market ...

CHANDIGARH: CRB Public School proudly hosted its Annual Function, Abhinandan 2025, on the morning of February 9 at Tagore Theatre, Chandigarh. The event was a grand celebration of talent, creativity, ...

Orlando Pirates will continue their defence of the Nedbank Cup by facing Baroka FC in the Round of 16 encounter at the ...

Despite continued heavy rush, Indian Railways is working on war footing to serve the devotees by bringing them in and taking ...

Woodbine went 3-0 at the Rolling Valley Conference Duals while Coon Rapids-Bayard won twice and West Harrison once and Bishop Heelan Catholic was also a winner in KMAland wrestling on ...

Ahead of Maghi Purnima Snan on Wednesday, Railway Minister Ashwini Vaishnaw on Monday said Prayagraj junction is functioning ...

Corbus Pharmaceuticals (CRBP) stock drops 12% after mixed Phase 1 trial results for its lead cancer candidate. Read more here.

Willis, a WTW business (NASDAQ: WTW), has announced the appointment of Guy Donahue as Cross Industry Midwest Property Broking Leader within Corporate Risk and Broking North America (CRB NA). In this ...